The aim of the project is to determine the regulatory element of Oct4 for CpG and CCWGG methylation/hydroxymethylation structure low malignancy and aggressive prostate cancer forms, to analyse expression patterns of Oct4 isoforms in order to identify aggressiveness of prostate cancer.
|Effective start/end date||14/09/20 → 13/09/21|
- Riga Stradins University: €20,000.00
- TCERG1L genes
- Prostate cancer
- DNA methylation degree
Field of Science
- 3.1 Basic medicine
Smart Specialization Area
- Biomedicine, medical technologies and biotechnology
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.